Skip to content
10-Q

Quarterly Report

TAXUS PHARMACEUTICALS HOLDINGS, INC.

0001549727-16-000172

← back to feed
Filed
Dec 13, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Dec 12, 2016 81.5M sh
Stockholders Equity Q1 2017 · Sep 30, 2016 −$51.11K
Stockholders Equity Q1 2017 · Jun 30, 2016 −$11.96K
Current Liabilities Q1 2017 · Sep 30, 2016 $82.02K
Current Liabilities Q1 2017 · Jun 30, 2016 $75.92K
Current Assets Q1 2017 · Sep 30, 2016 $27.91K
Current Assets Q1 2017 · Jun 30, 2016 $53.47K
Total Assets Q1 2017 · Sep 30, 2016 $30.91K
Total Assets Q1 2017 · Jun 30, 2016 $63.96K
Operating Cash Flow Q1 2017 · Sep 30, 2015 −$85.69K
Cash And Equivalents Q1 2017 · Sep 30, 2015 $58.08K
Cash And Equivalents Q1 2017 · Jun 30, 2015 $13.77K
Sga Expense Q1 2017 · Sep 30, 2015 $68.34K
Net Income Q1 2017 · Sep 30, 2015 −$62.86K
Gross Profit Q1 2017 · Sep 30, 2015 $5.48K
Cost Of Revenue Q1 2017 · Sep 30, 2015 $12.79K
Revenue Q1 2017 · Sep 30, 2015 $18.28K